← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Evorx Technologies, Inc.
Pasadena, CA
$2,552,738
Total funding
3
Grants
Funding over time
peak $1.1M · FY2013–18$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,552,738 · 3
By mechanism
R44$2,003,000 · 1
N43$549,738 · 2
Investigators at Evorx Technologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$1,144,342
R44 · FY2017 · CA
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$855,568
R44 · FY2016 · CA
SUPR Peptides for Targeted Radionuclide Delivery$299,990
N43 · FY2015 · CA
TOPIC 324 PHASE I; NOVEL IMAGING AGENTS TO EXPAND THE CLINICAL TOOL KIT FOR CANCE$249,748
N43 · FY2013 · CA
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$3,090
R44 · FY2018 · CA